Terms: = Prostate cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Diagnosis
54 results:
1. Diagnostic accuracy of qualitative and quantitative magnetic resonance imaging-guided contrast-enhanced ultrasound (MRI-guided CEUS) for the detection of prostate cancer: a prospective and multicenter study.
Liu Y; Lu D; Xu G; Wang S; Zhou B; Zhang Y; Ye B; Xiang L; Zhang Y; Xu H
Radiol Med; 2024 Apr; 129(4):585-597. PubMed ID: 38512615
[TBL] [Abstract] [Full Text] [Related]
2. Aggressive prostatic adenocarcinoma with urothelial-like morphology, with frequent CK7/CK20/HMWK expression and occasional diffuse neuroendocrine features: A clinicopathologic study of 12 cases.
Nguyen NJ; Sherman C; van der Kwast TH; Downes MR
Pathol Res Pract; 2024 Feb; 254():155105. PubMed ID: 38218041
[TBL] [Abstract] [Full Text] [Related]
3. Global viewpoints: updates on prostate cancer in Sub-Saharan Africa.
Jalloh M; Cassell A; Niang L; Rebbeck T
BJU Int; 2024 Jan; 133(1):6-13. PubMed ID: 37702258
[TBL] [Abstract] [Full Text] [Related]
4. A Narrative Synthesis of Literature on the Barriers to Timely diagnosis and Treatment of cancer in Sub-Saharan Africa.
Mwamba M; Lombe DC; Msadabwe S; Bond V; Simwinga M; Sentoogo Ssemata A; Muhumuza R; Seeley J; Mwaka AD; Aggarwal A
Clin Oncol (R Coll Radiol); 2023 Sep; 35(9):e537-e548. PubMed ID: 37302880
[TBL] [Abstract] [Full Text] [Related]
5. Analysis of cancer Research Projects in Sub-Saharan Africa: A Quantitative Perspective on Unmet Needs and Opportunities.
Davies L; Milner DA; Shulman LN; Kyokunda L; Bedada A; Vuylsteke P; Masalu N; Jackson P; Jennings N; Odunlami A; Mtshali P; Dugan U
JCO Glob Oncol; 2023 Jun; 9():e2200203. PubMed ID: 37290022
[TBL] [Abstract] [Full Text] [Related]
6. Comparing Risk for Second Primary cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for prostate cancer, 2002-2015.
Pithadia KJ; Advani PG; Citrin DE; Bekelman JE; Withrow DR; Berrington de Gonzalez A; Morton LM; Schonfeld SJ
JAMA Oncol; 2023 Aug; 9(8):1119-1123. PubMed ID: 37289449
[TBL] [Abstract] [Full Text] [Related]
7. Development and validation of a simple prostate cancer risk prediction model based on age, family history, and polygenic risk.
Dite GS; Spaeth E; Murphy NM; Allman R
Prostate; 2023 Jul; 83(10):962-969. PubMed ID: 37062910
[TBL] [Abstract] [Full Text] [Related]
8. Association between obstructive sleep apnoea and cancer: a cross-sectional, population-based study of the DISCOVERY cohort.
Palm A; Theorell-Haglöw J; Isakson J; Ljunggren M; Sundh J; Ekström MP; Grote L
BMJ Open; 2023 Mar; 13(3):e064501. PubMed ID: 36868588
[TBL] [Abstract] [Full Text] [Related]
9. prostate cancer Screening, Diagnostic, Treatment Procedures and Costs in Sub-Saharan Africa: A Situational Analysis.
Makau-Barasa LK; Manirakiza A; Carvalho AL; Rebbeck TR
Cancer Control; 2022; 29():10732748221084932. PubMed ID: 35350915
[TBL] [Abstract] [Full Text] [Related]
10. Clinical application of free/total PSA ratio in the diagnosis of prostate cancer in men over 50 years of age with total PSA levels of 2.0-25.0 ng ml
Gao XD; Miao Q; Zhang JL; Zhai JZ; Gui XM; Cai YH; Niu Q; Cai B
Asian J Androl; 2022; 24(2):195-200. PubMed ID: 34916475
[TBL] [Abstract] [Full Text] [Related]
11. The Role of Pentraxin-3, Fetuin-A and Sirtuin-7 in the diagnosis of prostate cancer.
Güzel Ö; Kösem A; Aslan Y; Asfuroglu A; Balci M; Senel C; Tuncel A
Urol J; 2021 Oct; 19(3):196-201. PubMed ID: 34655076
[TBL] [Abstract] [Full Text] [Related]
12. Presentation, patterns of care, and outcomes of patients with prostate cancer in sub-Saharan Africa: A population-based registry study.
Seraphin TP; Joko-Fru WY; Hämmerl L; Griesel M; Mezger NCS; Feuchtner JC; Adoubi I; Egué MD; Okerosi N; Wabinga H; Hansen R; Vuma S; Lorenzoni C; Coulibaly B; Odzebe SW; Buziba NG; Aynalem A; Liu B; Medenwald D; Mikolajczyk RT; Efstathiou JA; Parkin DM; Jemal A; Kantelhardt EJ
Cancer; 2021 Nov; 127(22):4221-4232. PubMed ID: 34328216
[TBL] [Abstract] [Full Text] [Related]
13. prostate cancer survival in sub-Saharan Africa by age, stage at diagnosis, and human development index: a population-based registry study.
Seraphin TP; Joko-Fru WY; Manraj SS; Chokunonga E; Somdyala NIM; Korir A; N'Da G; Finesse A; Wabinga H; Assefa M; Gnangnon F; Hansen R; Buziba NG; Liu B; Kantelhardt EJ; Parkin DM
Cancer Causes Control; 2021 Sep; 32(9):1001-1019. PubMed ID: 34244896
[TBL] [Abstract] [Full Text] [Related]
14. Diagnostic efficiency of systemic immune-inflammation index in fusion prostate biopsy.
Sonmez G; Demirtas T; Tombul ST; Akgun H; Demirtas A
Actas Urol Esp (Engl Ed); 2021 Jun; 45(5):359-365. PubMed ID: 34088435
[TBL] [Abstract] [Full Text] [Related]
15. The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world population.
Westgeest HM; Kuppen MCP; van den Eertwegh AJM; de Wit R; Bergman AM; van Moorselaar RJA; Coenen JLLM; van den Bergh ACM; Somford DM; Mehra N; van Oort IM; Aben KKH; Gerritsen WR; Uyl-de Groot CA
Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):871-879. PubMed ID: 33746212
[TBL] [Abstract] [Full Text] [Related]
16. Could aspirin be a lifesaver for prostate cancer patients in prostate cancer-specific mortality?: an update systematic review and meta-analysis.
Zhou J; Xia S; Li T; Liu R
BMC Cancer; 2019 Dec; 19(1):1186. PubMed ID: 31805980
[TBL] [Abstract] [Full Text] [Related]
17. Predicting prostate cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort Study.
Zelic R; Garmo H; Zugna D; Stattin P; Richiardi L; Akre O; Pettersson A
Eur Urol; 2020 Feb; 77(2):180-188. PubMed ID: 31606332
[TBL] [Abstract] [Full Text] [Related]
18. Changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy.
Narita S; Nomura K; Hatakeyama S; Takahashi M; Sakurai T; Kawamura S; Hoshi S; Ishida M; Kawaguchi T; Ishidoya S; Shimoda J; Sato H; Mitsuzuka K; Tochigi T; Tsuchiya N; Ohyama C; Arai Y; Nagashima K; Habuchi T
Cancer Med; 2019 Nov; 8(15):6566-6577. PubMed ID: 31508900
[TBL] [Abstract] [Full Text] [Related]
19. Incidence of skeletal-related events in patients with breast or prostate cancer-induced bone metastasis or multiple myeloma: A 12-year longitudinal nationwide healthcare database study.
Baek YH; Jeon HL; Oh IS; Yang H; Park J; Shin JY
Cancer Epidemiol; 2019 Aug; 61():104-110. PubMed ID: 31176960
[TBL] [Abstract] [Full Text] [Related]
20. Who Dies From prostate cancer? An Analysis of the Surveillance, Epidemiology and End Results Database.
Roy S; Morgan SC
Clin Oncol (R Coll Radiol); 2019 Sep; 31(9):630-636. PubMed ID: 31130340
[TBL] [Abstract] [Full Text] [Related]
[Next]
